Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SUBA-itraconazole with Cisplatin/Gemcitabine in Metastatic Squamous NSCLC
NCT01752023Phase 2Terminated
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center
- Start
- Mar 2013
- Primary completion
- Apr 2014
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of SUBA itraconazole in squamous cell carcinoma of the lung (SCCL), sponsored by Sidney Kimmel Comprehensive Cancer Center. Started Mar 2013; status: terminated.
02
Drugs
SUBA itraconazole
03
Conditions
squamous cell carcinoma of the lung (SCCL)
Beyond the preview
Go deeper on NCT01752023.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01752023.